Inaktiver Wert

Andere Sprachen Tryp Therapeutics Inc. Canadian Securities Exchange

Aktien

Tryptamine Therapeutics Partners with Lucid Health to Advance TRP-8803's Product Registration in Australia	19.06.
Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118%	29.05.
Tryp Therapeutics Files Amended Financial Statements for the Six Months Ended February 29, 2024	17.05.
Tryptamine Therapeutics Limited Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	29.04.
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 18-DEC-2023.	18.12.
3,043,860 Common Shares of Tryptamine Therapeutics Limited are subject to a Lock-Up Agreement Ending on 20-JUN-2023.	20.06.23

Keine Ergebnisse zu dieser Suche